Artelo Biosciences flagged for possible Nasdaq delisting under new $5 million MVLS rule

PUBT · 1d ago
Artelo Biosciences flagged for possible Nasdaq delisting under new $5 million MVLS rule
  • Artelo Biosciences flagged potential Nasdaq delisting risk tied to a new $5 million market value of listed securities minimum.
  • SEC cleared the rule on July 22, 2026; Nasdaq later imposed a temporary stay, leaving timing uncertain.
  • Nasdaq filed a proposed change on Oct. 5, 2026 to make the rule effective when the stay ends; comments due Oct. 29, 2026.
  • Artelo was among roughly 180 Nasdaq issuers initially identified below the $5 million threshold.
  • Management is evaluating compliance options if the rule takes effect, including use of its at-the-market equity program.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artelo Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-26-001665), on October 09, 2026, and is solely responsible for the information contained therein.